skip to Cookie NoticeSkip to contents

Your health and safety remain our top priority: Learn about our Safe Care Commitment | Use our Prescreen app before arrival for faster entry | Read the COVID-19 Vaccine FAQs

Header Skipped.



View all Press Releases
January 27, 2022
Announcing Mass General Brigham Enterprise Pathology

David Louis, MD, has been appointed Mass General Brigham chief of enterprise pathology and will oversee the new enterprise service, Mass General Brigham enterprise laboratory service (MGBELS).  Read More...

January 25, 2022
Randomized controlled trial offers insights on how the timing of dinner and genetics affect individuals' blood sugar control

Connections among food intake, melatonin levels and genetics may be important for diabetes risk.  Read More...

January 13, 2022
Immunotherapy Combination Shown to Benefit Some Patients with Non-Small Cell Lung Cancer Resistant to Single Immunotherapy

A combination of two drugs that open the floodgates to an immune system attack on cancer curtailed tumor growth in some patients with non-small cell lung cancer (NSCLC) that was resistant to a single immunotherapy agent, results from a recent clinica  Read More...


View More News Clips